SLRPs are primarily considered to play a role as organizers of extracellular matrices. BGN, decorin and other members of the family of SLRPs interact with fibrillar collagens, thereby modulating fibril formation and stability (reviewed in [1] [2] [3] . Targeted disruption of the BGN gene resulted in abnormal collagen fibril morphology (4) and in an osteoporosis-like phenotype (5) , possibly due to defects in bone marrow stromal cells (6) . Additionally, BGN as well as decorin modulate adhesion of cells to matrix glycoproteins like fibronectin and thrombospondin (7, 8) . Interactions with cell membrane components have also to be taken into account because BGN is most abundant near the cell surface (9) . Several SLRPs were
shown to form complexes with TGF-β (10), which in case of decorin affects the biological activity of the cytokine (11, 12) . No such properties have been reported so far for BGN/TGF-β complexes (12) .
It is becoming increasingly clear that, in addition to their interaction with TGF-β, small proteoglycans are also directly involved in cell signalling (3) . Decorin has been shown to interact with members of the ErbB-receptor family (13) which leads to the induction of the cyclin-dependent kinase inhibitor p21 WAF1/CIP1 (14) and growth arrest of certain tumor cells. In endothelial cells (15) , renal tubular epithelial cells (16) and macrophages (17) decorin protects against apoptosis and induces additionally p27 KIP1 . BGN seems to be required for endothelial cell migration (18) . It may also affect signal transduction during growth and differentiation via induction of p27 KIP1 (19) . Further signalling functions may be deduced from the capability of BGN to interact via its glycosaminoglycan chains with dystroglycan (20) . BGN has been shown to stimulate growth and differentiation of monocytic lineage cells from various lymphatic organs (21) .
In the normal kidney BGN is found primarily in the tubulointerstitium. The normal glomerulus contains trace amounts of BGN produced by mesangial and endothelial cells as well as podocytes (22) . In contrast, in advanced stages of glomerulosclerosis high amounts of BGN are deposited in the mesangial matrix (23, 24) . In obstructive nephropathy BGN becomes up-regulated, an effect which is dramatically enhanced in decorin-deficient mice.
This increase is primarily due to the appearance of BGN-expressing macrophages (16) . Taken together, these data suggest a regulatory role of BGN during the development of renal diseases (23, 24) .
Nitric oxide, produced either in physiological amounts by endothelial cells and macrophages or overproduced by the inducible isoform of NO synthase (iNOS), has been shown to be an important regulatory factor in a number of inflammatory diseases (reviewed in 25, 26) . In the kidney, NO triggers the expression of proinflammatory and protective gene products in various types of glomerulonephritis (27, 28) . Besides infiltrating cells, renal mesangial cells (MCs), exposed to inflammatory cytokines such as interleukin-1β (IL-1β) or tumor necrosis factor-α (TNFα), start to express iNOS followed by enhanced generation of NO (29) . NO exerts complex regulatory actions on proliferation (30, 31) , adhesion (32) and death of MCs (33, 34) .
Here we show for the first time, using PCR-based analysis of differential mRNA expression patterns of MCs exposed to exogenously or endogenously produced NO, that BGN is a NO-regulated gene in MCs both in vitro and in vivo and that it is involved in the modulation of the extent of adhesion, proliferation and survival of MCs.
EXPERIMENTAL PROCEDURES
Reagents -Radiochemicals and the "ready prime" DNA labeling kit were obtained Cell Culture and Stimulation -Rat MCs were cultured as described previously (35) .
They were grown in RPMI 1640 supplemented with 10% heat-inactivated fetal calf serum (FCS), 2 mM glutamine, 5 ng/ml insulin, 100 U/ml penicillin and 100 µg/ml streptomycin for 8-19 passages. To obtain quiescent cells, MCs were maintained in serum-free DMEM supplemented with 0.1 mg/ml of fatty acid-free bovine serum albumin for 24 h prior to the addition of buffer, DETA-NO (0.063-1 mM), L-NIL (0.3-3 mM), or IL-1β (2 nM). Viability of MCs was not altered under the conditions used for the experiments, as determined by lactate dehydrogenase release into the culture medium using a cytotoxicity detection kit (Roche Applied Science, Mannheim, Germany).
Analysis of the mRNA Expression Pattern in MCs by RAP-PCR -In the present work
BGN was identified as a nitric oxide-regulated gene in a set of experiments performed analogously as in a previous study on NO-mediated regulation of macrophage inflammatory protein 2 (MIP-2), using the same conditions and primers (36) . Briefly, mRNA from MCs was prepared using an mRNA isolation kit (Stratagene) followed by the low stringency RAP-PCR protocol provided by the manufacturer, and using α-33 P-dCTP as radioactive precursor.
As an internal control the reverse transcription step was performed additionally using the primer G5 that matched with the reverse strand of rat GAPDH cDNA at position 705-724 (GenBank accession number M17701), while during the PCR steps primer G3, that matched with the coding strand of rat GAPDH cDNA at position 131-150, was also present. The PCR was performed for one cycle at an annealing temperature of 35° C and for 40 further cycles at 53° C. The products were separated on a 4% sequencing gel. After an overnight exposition to X-ray film, bands of interest were excised, reamplified and blunted using Pfu polymerase (Promega, Mannheim, Germany) according to the high stringency protocol mentioned above and sequenced. For further analysis, the PCR fragments were cloned into EcoRV sites of pBluescript KS + (Stratagene).
Nitrite Analysis -To verify endogenous NO production, nitrite as a stable end product of NO metabolism was measured routinely in culture media using the Griess reagent (Merck, Darmstadt, Germany).
Rat Model of Glomerulonephritis -
The anti-Thy-1 glomerulonephritis (anti-Thy 1-GN) was induced as described before (36) . L-NIL, a selective inhibitor of iNOS, was administered intravenously at a dose of 5 mg/kg body weight to control and nephritic rats 45 min before and 8 h after anti-Thy 1 injection. Kidneys were harvested 16 h (n = 5 animals per group) after injection of the anti-Thy 1.1 antibody. Monitoring of systolic blood pressure and isolation of glomeruli were performed as described (36, 37) .
Northern Blot Analysis and In situ Hybridization -Total RNA was extracted from isolated glomeruli using TRI-zol (Invitrogen). Northern blots were performed and analysed as described previously (37) . In situ hybridization of rat renal sections was performed in parallel with the sense and antisense probes for rat BGN (24, 37) . (24) . Glomerular homogenates containing equal amounts of glomeruli were mixed with DEAE Trisacryl M (100 mg wet weight), equilibrated with buffer 1 and mixed by rotation for 1 h at 4° C. The samples were washed sequentially with 3 ml of buffer 1, 3 ml of urea-free buffer 1, and 3 ml of urea-free buffer 1 containing 0.3 M NaCl.
Determination of BGN in Isolated Rat
Elution was achieved with 1.5 ml urea-free buffer 1 containing 1 M NaCl. Upon adding 5 vol of methanol and 1 vol of chloroform followed by freezing on dry ice, proteoglycans were collected after thawing at the interphase between chloroform and aqueous methanol. The upper phase was removed, and proteoglycans were precipitated to the bottom of the tube by adding again 5 vol of methanol. The proteoglycans from cell culture supernatants, MCs or glomerular homogenates were digested with chondroitin ABC lyase (Seikagaku Kogyo, Tokyo, Japan) to remove chondroitin sulfate and dermatan sulfate chains. BGN from plasma or urine samples was semipurified as described previously (24) . According to the analysis of Untreated and chondroitin ABC lyase-treated samples from MCs and their culture supernatants were subjected to SDS-polyacrylamide gel electrophoresis followed by Western blotting (38) . Plasma, urine and glomerular samples were transferred to nitrocellulose membranes using the Bio-Dot Microfiltration Apparatus (BioRad, Hercules, CA, USA (39) . Appropriate radioactive fractions were tested by a dot blot assay with the anti-biglycan antibody (LF-106) as described above. Biglycan was eluted at a K av -value of 0.27. Supernatants of the samples labelled with [4, H]leucine were purified on a concanavalin A-Sepharose column (Fluka, Taufkirchen, Germany) and treated with chondroitin ABC lyase prior to SDS-PAGE (12.5 % total acrylamide in the separation gel) and fluorography (38) . MCs are stained with both annexin V-Cy3 and 6-carboxyfluorescein. In addition, MCs plated onto 8-well chamber slides were assayed by TUNEL-staining (Roche Applied Science) as described before (16) .
Assessment of Adhesion, Proliferation and Survival of Cultured MCs
To exclude binding of TNFα to BGN, which might influence the cytokine´s activity, 50 µg of BGN were immobilized on nitrocellulose membranes using a Bio-Dot Microfiltration Apparatus, and the membrane was blocked with 5 % bovine serum albumin for 1 h at 37° C. The membranes were incubated with 2 nM of TNFα in culture medium for 2 h at 37° C to which, after removal of the membranes, 100 nM of cycloheximide were added.
Thereafter, this medium was used for the induction of MC death. Cell death was quantified after 24 h using the cell death detection ELISA mentioned above. In order to exclude that the effects on adhesion, proliferation and cell survival of MCs might have been due to other active agents in the BGN preparation, the purity of the BGN preparation was monitored by SDS-PAGE and silver staining (39 Other Procedures -Protein concentrations were determined using the BCA Protein Assay Reagent (Pierce, Rockford, IL, USA). Expression of human BGN in 293 kidney cells and purification of the native proteoglycan were performed as described previously (39) .
Statistics -Results are expressed as means ± SEM. Statistical analysis was performed by the unpaired Student's t-test. Significance was accepted at the 5% level.
RESULTS

Identification of BGN as a NO-regulated Gene by RAP-PCR -Previously we have
addressed the effects of the iNOS inhibitor L-NMMA on cytokine-induced gene expression (35, 42) . In the present work we investigated whether the NO-donor DETA-NO is able to modulate IL-1β-induced mRNA patterns in rat MCs. Therefore, the effects of IL-1β (2.0 nM) and IL-1β + DETA-NO (0.5 mM) were analysed by RAP-PCR as described (36) . The resulting mRNA expression pattern is displayed in Figure 1A . GAPDH primers for low These experiments confirmed that exogenously administered NO down-regulates BGN mRNA expression in a time-and dose-dependent manner. Figure 3A ). Similar effects of the NO-donor were observed when the concentration of radiolabelled BGN core protein was normalized by the protein content of cultured MCs (data not shown).
Effects of Exogenous and Endogenous NO on BGN Secretion by MCs
In the standard purification protocol, the decorin-free proteoglycan mixture was In case of long-term incubation experiments, cell-associated BGN was below the limit of detection after pulse labelling ( Figure 3A) . Previous studies have shown that BGN is not retained in the glomerular extracellular matrix to a significant degree (24) . In agreement with these observations the present results of immunological quantification of BGN core protein in glomerular extracts from control and nephritic animals (with and without L-NIL treatment) showed that BGN was not retained in the glomerular matrices from control or nephritic rats (data not shown). It is likely that most of the BGN is eliminated from the glomerulus either via the circulation and/or through glomerular ultrafiltration. However, we were not able to further test this hypothesis as plasma and urinary levels of BGN were below the limits of detection.
Expression of iNOS and BGN mRNAs in Glomeruli from
Effects of BGN on Adhesion, Proliferation and Survival of Cultured MCs -The
presence of BGN in concentrations of 2.5-50 µg/ml led to a dose-dependent reduction in MC adhesion, when MCs were plated under serum-free conditions on culture wells coated with human non-fibrillar type I collagen or fibronectin. Quantification of the relative attachment of MCs is shown in Figure 7A using the CytoMatrix Cell Adhesion Strips assay. Based on these findings, all further experiments were performed under serum-free conditions using BGN in a concentration of 5µg/ml. Regarding the underlying mechanism of the antiadhesive properties of BGN, we explored whether BGN binds to type I collagen and/or fibronectin, thereby inhibiting the attachment of MCs to these substrates. In a solid-phase assay binding of Radiolabelled BGN-derived glycosaminoglycan chains alone were not capable to bind to any of tested substrates (data not shown).
In the next step we addressed the issue, whether BGN might bind to the cell surface of stimuli which was probably due to some low-rate proliferation. In resting MCs proliferation could not be induced by BGN (Table I) . As expected, FCS stimulated proliferation of MCs after 24h as measured by two independent assays based either on direct incorporation of [ 3 H]thymidine or on the activity of mitochondrial dehydrogenases (Table I) . Coincubation with FCS and BGN significantly reduced the proliferation rate of MCs (Table I) . In order to evaluate the biological relevance of this finding, we stimulated the proliferation of MCs with PDGF-BB, a major mitogenic growth factor that is frequently upregulated in glomerular disease and which is considered to be responsible for MC proliferation in vivo (43) .
Incubation with 20 ng/ml of PDGF-BB resulted in marked proliferation of MCs which was significantly reduced in the presence of BGN (Table I) (Table   II) . For further differentiation between apoptosis and necrosis, the localization of annexin V in the plasma membrane and the hydrolysis of carboxyfluorescein were studied. Figure 9A shows and the presence of BGN had no effect on its activity. Addition of BGN had also no effect on the activity of caspase-3 in control MCs between 2 -12 h (data not shown). These findings suggest that BGN protects MCs from apoptosis, at least partially, due to inhibition of caspase-3 activity.
We also addressed the possibility that the antiapoptotic effects of BGN might have been caused by complex formation of TNFα with BGN and subsequent inactivation of the cytokine. When TNFα was preincubated with BGN immobilized on nitrocellulose, its ability to induce MC death was not affected, as measured after 24 h by the Cell Death Detection ELISA (preincubation with immobilized BGN: 1018 ± 91 arbitrary units vs. preincubation with nitrocellulose: 987 ± 98 arbitrary units; n = 3, p>0.05). These data demonstrate that the antiapoptotic effect of BGN was not due to binding of TNFα but reflects an intrinsic property of this proteoglycan.
In order to assess whether other active moieties in our BGN preparation might have been responsible for the effects on adhesion, proliferation and survival of MCs, we performed SDS-PAGE followed by silver staining in order to demonstrate the purity of the BGN preparation (Fig. 8C ). Only the typical staining for BGN could be observed without any additional bands. Moreover, 50 µg of purified BGN were loaded on a DEAE Trisacryl M column and after washing the unbound material was examined in adhesion, proliferation and cell death assays. This unbound material had no effects in any of the bio-assays performed (data not shown) suggesting that the observed alterations in MCs were indeed due to BGN rather than contaminants in the preparation. Our in vitro findings in cultured MCs were confirmed in vivo in a rat model of mesangioproliferative glomerulonephritis, characterized by enhanced NO formation during the early phase of mesangiolysis (44, 45) . In agreement with previous studies we found an early induction of iNOS mRNA expression in isolated glomeruli from nephritic rats (46) . In parallel, down-regulation of BGN mRNA was observed which was at least partially reversible by the systemic administration of L-NIL, again indicating a NO-dependent mechanism. The in vivo observation that L-NIL only partially reversed the down-regulation of BGN might be explained by the fact that in glomeruli BGN is expressed not only in MCs but also in endothelial cells and podocytes (22) . As BGN was down-regulated in all types of glomerular cells and L-NIL is a selective inhibitor of iNOS (47), it is conceivable that not all glomerular NO synthases were suppressed. Moreover, there might be other biologically reactive radicals, produced as a consequence of an increased NO production, which may have a strong impact on gene expression (48, 49) . In contrast to the immediate down-regulation of BGN upon induction of the anti-Thy-1-induced glomerulonephritis, BGN mRNA became up-regulated 48 h after administration of the antibody. This effect, however, might at least partly be due to an increased TGF-β production, as has been reported previously (37, 50) .
Our differential display data indicated that the NO-mediated effects on proteoglycan transcription in MCs seemed to be specific for BGN. The expression of the closely related proteoglycan decorin was not affected by NO neither in vitro in cultured MCs nor in vivo in isolated glomeruli. However, NO modulates the synthesis of other extracellular matrix components such as collagen, fibronectin and laminin in MCs (49, 51) .
One of the most intensively investigated features of NO is its effect on cell death (33, 34) . In glomerular MCs NO is capable to trigger cell death (33, 52) . It has been proposed that the balance between NO and superoxide determines either an apoptotic or a necrotic outcome (34) . Here we show that BGN displays an protective effect on MCs, preventing both apoptotic and necrotic cell death induced by TNFα and cycloheximide. Normally, rat MCs are resistant to TNFα-induced cell death, but become susceptible to the apoptotic effects of TNFα by treatment with cycloheximide due to the sustained activation of c-jun N-terminal protein kinase (41) . In agreement with these studies (41) we observed mainly apoptosis up to 12h.
Moreover, the antiapoptotic effects of BGN on MCs were due to inhibition of the effector caspase-3. The presence of necrotic MCs observed at later stages may reflect the fact that we followed MCs for prolonged periods of time after the stimulation of cell death. Up to now, not much is known about the effects of BGN on cell survival except that the rate of cell death has been found to be enhanced in BGN-deficient bone marrow stromal cells (6) . Previous reports have primarily dealt with antiapoptotic effects of decorin in selected cell types (15) (16) (17) .
During the acute phase of mesangiolysis in the anti-Thy-1 nephritis, when iNOS was overexpressed and BGN was simultaneously down-regulated, both apoptotic and necrotic cell death has been described previously (53, 54) . In light of the present investigation we postulate that NO-induced MC death is at least partially mediated by NO-dependent down-regulation of BGN.
In a number of glomerular diseases apoptosis and/or necrosis of MCs have been observed to be preceeded by lobular disintegration of the mesangium with detachment of MCs (55) . The pathogenetic mechanism underlying detachment of MCs is still poorly understood.
NO has been reported to inhibit adhesion and spreading of MCs on various extracellular matrices, mediated primarily by cGMP-dependent signalling pathways (32) . Another important biological effect of NO is related to its antiproliferative properties in MCs (30, 31) . BGN has been suggested to act as a growth factor inducing proliferation and differentiation of monocytic cells (21) , whereas in pancreatic cancer cells proliferation was suppressed by BGN (19) . In resting MCs proliferation could not be induced by BGN. More importantly, BGN counteracted the effects of growth factors being present in fetal calf serum.
Serum-treated cells are considered to be exposed to a pro-inflammatory environment due to the presence of growth factors and cytokines released during serum preparation. What is even more important, BGN is capable to inhibit the proliferation of MCs induced by PDGF-BB, a major mitogenic growth factor frequently involved in glomerular disease (43) . Therefore, it is tempting to speculate that BGN might be an important factor for regulating the proliferation in renal diseases. Further studies, however, are needed to elucidate those pathways by which BGN exerts its antiproliferative effects in MCs.
The in vitro effects of BGN in MCs described above correspond well to the events occurring in vivo in anti-Thy-1 glomerulonephritis, which is characterized by wide-spread 
